Details of the Drug
General Information of Drug (ID: DMUACZF)
Drug Name |
(1-Amino-ethyl)-phosphinic acid
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
1-Aminoethylphosphinic acid; AMINOETHYLPHOSPHINIC ACID; 74333-44-1; 71937-28-5; 1-Aminoethylphosphinate; (1-Aminoethyl)phosphonous acid; Aminoethylphosphinic acid [INCI]; Phosphinic acid, (1-aminoethyl)-; Phosphinic acid, P-(1-aminoethyl)-; AC1O4DZP; Phosphinic acid, (1-aminoethyl)-, (+/-)-; 1-aminoethyl phosphinic acid; SCHEMBL579981; (1-aminoethyl)phosphinic acid; (1-Aminoethyl)-phosphinic acid; CTK5D5277; TVKUNRSARHGLNB-UHFFFAOYSA-N; 1-aminoethyl-hydroxy-oxophosphanium; AKOS006273172; Phosphinic acid, (1-aminoethyl)-, (-)-
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 107.05 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | -1.2 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 1 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 3 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||